Affymetrix Launches Program to Advance Cancer Research
Partnership With Leading Scientists Aims to Accelerate Breakthroughs in More Than 10 Types of Cancers
The studies selected for the Collaborations in Cancer Research Program incorporate a number of different microarray-based applications, including copy number analysis, chromatin immunoprecipitation (ChIP), gene expression and splicing pattern analysis. In addition to helping participants obtain tools and training, Affymetrix will also provide forums where investigators can exchange knowledge and share best practices.
Participants in the Collaborations in Cancer Research Program were selected on the basis of past contributions to their respective fields, and the potential to make significant advancements in their current research.
Later this year, Affymetrix will expand the Collaborations in Cancer Research Program to selected groups in North America and Japan.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.